NCT05416710 - Universal Germline Testing in the Community | Biotech Hunter

Enrollment

1,000

Participants

Timeline

Start Date

June 1, 2022

Primary Completion Date

June 1, 2025

Study Completion Date

June 1, 2025

Conditions

CancerSolid TumorSolid Tumor, Adult

Interventions

DIAGNOSTIC_TEST

Invitae's 84 gene multi-cancer panel.

Invitae's Multi-Cancer panel analyzes 84 genes associated with hereditary cancers across major organ systems.

Trial Locations (1)

RECRUITING

Carolina Blood and Cancer Care Associates, PA', Rock Hill